Communiqués Chimerix, Inc. Börse Stuttgart

Actions

Marché Fermé - Börse Stuttgart Autres places de cotation 10:00:48 05/07/2024			Varia. 5j.	Varia. 1 janv.
0,819 ^EUR	+4,33%		+0,12%	+0,54%

01/05	Transcript : Chimerix, Inc., Q1 2024 Earnings Call, May 01, 2024
01/05	Chimerix, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	05/07	AQ
Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference	30/05	AQ
Chimerix : Corporate Presentation	03/05	PU
Chimerix: Q1 Earnings Snapshot	01/05	AQ
Chimerix Reports First Quarter 2024 Financial Results and Provides Operational Update	01/05	AQ
Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024	24/04	AQ
Chimerix Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	17/04	AQ
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	16/04	AQ
Chimerix Appoints Marc D. Kozin to Board of Directors	21/03	AQ
Chimerix: Q4 Earnings Snapshot	29/02	AQ
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update	29/02	AQ
Chimerix to Present at TD Cowen 44th Annual Health Care Conference	27/02	AQ
Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024	22/02	AQ
Chimerix Appoints Lisa Decker to Board of Directors	29/12	AQ
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer	04/12	AQ
Chimerix Reports Inducement Grant under Nasdaq Listing Rule 5635(4)	27/11	AQ
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	24/11	AQ
Chimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer	16/11	AQ
Chimerix : Corporate Presentation	02/11	PU
Chimerix: Q3 Earnings Snapshot	02/11	AQ

Aucun résultat pour cette recherche